Ashlee Waugh, MD
Internal Medicine · Edmond, OKNPI 1831308899
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,581 of the $14,631 with a category attached, or 65.5%. 60 manufacturers reported payments, led by Merz North America, Inc. at 34.2% of the total. Reporting peaked in 2023 at $6,665 and has fallen 76.4% since, to $1,574 in 2025. Among internal medicine clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 576 payments — averaging $25.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$5K
- AbbVie$2K
- Novo Nordisk$767
- Lilly USA, LLC$630
- Otsuka America Pharmaceutical, Inc.$592
- IBSA Pharma Inc.$422
- plus $5K from 54 others
What the payments were for
- Consulting fees$5,00034%
- Food & beverage$9,58165%
- Education$500%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$14,631 in reported general payments places this provider in the 95th percentile of 840 internal medicine providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 49 | $67,353 |
| OzempicSemaglutide | 14 | $13,021 |
| VyvanseLisdexamfetamine Dimesylate | 19 | $7,146 |
| ProgesteroneProgesterone, Micronized | 138 | $3,541 |
| SynthroidLevothyroxine Sodium | 33 | $2,949 |
| Lisdexamfetamine Dimesylate | 19 | $2,714 |
| Estradiol (Once Weekly)Estradiol | 45 | $2,452 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 12 | $2,241 |
| Testosterone Cypionate | 63 | $2,239 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 35 | $1,069 |
| Levothyroxine Sodium | 110 | $1,001 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 11 | $968 |
| Np ThyroidThyroid,pork | 18 | $937 |
| Estradiol | 27 | $765 |
| Bupropion XlBupropion Hcl | 16 | $647 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $630 | $67,35349 claims |
| Novo NordiskOzempic | $767 | $13,02114 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $270 | $7,14619 claims |
| AbbVieSynthroid | $2,243 | $2,94933 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $235 | $1,001110 claims |
| Acella Pharmaceuticals, LLCNp Thyroid | $50 | $93718 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 840 internal medicine providers in Oklahoma.
Other internal medicine in Edmond
- Todd KrehbielEdmond$21K
- William MorganEdmond$13K
- Thomas KupiecEdmond$12K
- Shawn SchlinkeEdmond$9K
- Emily ReedEdmond$8K
- Brian LevyEdmond$8K
- Steve EgwuonwuLawton$464K
- Jesse RichardsTulsa$279K
- Ryan MorganOklahoma City$235K
- Madhuri LadTulsa$173K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.